{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T19:10:13Z","timestamp":1683659413249},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2006,11,14]],"date-time":"2006-11-14T00:00:00Z","timestamp":1163462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,11,14]],"date-time":"2006-11-14T00:00:00Z","timestamp":1163462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1007\/s00280-006-0378-3","type":"journal-article","created":{"date-parts":[[2006,11,15]],"date-time":"2006-11-15T20:02:41Z","timestamp":1163620961000},"page":"341-349","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy of SSG and SSG\/IFN\u03b12 against human prostate cancer xenograft tumors in mice: a role for direct growth inhibition in SSG anti-tumor action"],"prefix":"10.1007","volume":"60","author":[{"given":"Jing","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Lindner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Farver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernest C.","family":"Borden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taolin","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,11,14]]},"reference":[{"key":"378_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0009-2797(97)00146-4","volume":"111\u2013112","author":"ME Anderson","year":"1998","unstructured":"Anderson ME (1998) Glutathione: an overview of biosynthesis and modulation. Chem Biol Interact 111\u2013112:1\u201314","journal-title":"Chem Biol Interact"},{"key":"378_CR2","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1200\/JCO.1994.12.1.194","volume":"12","author":"HH Bailey","year":"1994","unstructured":"Bailey HH, Mulcahy RT, Tutsch KD, Arzoomanian RZ, Alberti D, Tombes MB, Wilding G, Pomplun M, Spriggs DR (1994) Phase I clinical trial of intravenous l-buthionine sulfoximine and melphalan: an attempt at modulation of glutathione. J Clin Oncol 12:194\u2013205","journal-title":"J Clin Oncol"},{"key":"378_CR3","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1093\/jnci\/89.23.1789","volume":"89","author":"HH Bailey","year":"1997","unstructured":"Bailey HH, Ripple G, Tutsch KD, Arzoomanian RZ, Alberti D, Feierabend C, Mahvi D, Schink J, Pomplun M, Mulcahy RT, Wilding G (1997) Phase I study of continuous-infusion l-s, r-buthionine sulfoximine with intravenous melphalan. J Natl Cancer Inst 89:1789\u20131796","journal-title":"J Natl Cancer Inst"},{"key":"378_CR4","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3109\/08923979409007097","volume":"16","author":"W Budzynski","year":"1994","unstructured":"Budzynski W, Radzikowski C (1994) Cytotoxic cells in immunodeficient athymic mice. Immunopharmacol Immunotoxicol 16:319\u2013346","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"378_CR5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S1074-7613(00)80300-3","volume":"4","author":"DN Burshtyn","year":"1996","unstructured":"Burshtyn DN, Scharenberg AM, Wagtmann N, Rajagopalan S, Berrada K, Yi T, Kinet JP, Long EO (1996) Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. Immunity 4:77\u201385","journal-title":"Immunity"},{"key":"378_CR6","doi-asserted-by":"publisher","first-page":"13066","DOI":"10.1074\/jbc.272.20.13066","volume":"272","author":"DN Burshtyn","year":"1997","unstructured":"Burshtyn DN, Yang W, Yi T, Long EO (1997) A novel phosphotyrosine motif with a critical amino acid at position -2 for the SH2 domain-mediated activation of the tyrosine phosphatase SHP- 1 [in process citation]. J Biol Chem 272:13066\u201313072","journal-title":"J Biol Chem"},{"key":"378_CR7","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1093\/intimm\/11.12.1999","volume":"11","author":"JD Carter","year":"1999","unstructured":"Carter JD, Neel BG, Lorenz U (1999) The tyrosine phosphatase SHP-1 influences thymocyte selection by setting TCR signaling thresholds. Int Immunol 11:1999\u20132014","journal-title":"Int Immunol"},{"key":"378_CR8","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ijrobp.2004.12.088","volume":"62","author":"P Chinnaiyan","year":"2005","unstructured":"Chinnaiyan P, Vallabhaneni G, Armstrong E, Huang SM, Harari PM (2005) Modulation of radiation response by histone deacetylase inhibition. Int J Radiat Oncol Biol Phys 62:223\u2013229","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"378_CR9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1080\/10408360500523878","volume":"43","author":"JM Estrela","year":"2006","unstructured":"Estrela JM, Ortega A, Obrador E (2006) Glutathione in cancer biology and therapy. Crit Rev Clin Lab Sci 43:143\u2013181","journal-title":"Crit Rev Clin Lab Sci"},{"key":"378_CR10","doi-asserted-by":"crossref","first-page":"7003","DOI":"10.4049\/jimmunol.175.10.7003","volume":"175","author":"K Fan","year":"2005","unstructured":"Fan K, Zhou M, Pathak MK, Lindner DJ, Altuntas CZ, Tuohy VK, Borden EC, Yi T (2005) Sodium stibogluconate interacts with IL-2 in anti-Renca tumor action via a T cell-dependent mechanism in connection with induction of tumor-infiltrating macrophages. J Immunol 175:7003\u20137008","journal-title":"J Immunol"},{"key":"378_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1006\/excr.1999.4668","volume":"253","author":"GS Feng","year":"1999","unstructured":"Feng GS (1999) Shp-2 tyrosine phosphatase: signaling one cell or many. Exp Cell Res 253:47\u201354","journal-title":"Exp Cell Res"},{"key":"378_CR12","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1073\/pnas.90.2.393","volume":"90","author":"K Forsberg","year":"1993","unstructured":"Forsberg K, Valyi-Nagy I, Heldin CH, Herlyn M, Westermark B (1993) Platelet-derived growth factor (PDGF) in oncogenesis: development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB. Proc Natl Acad Sci USA 90:393\u2013397","journal-title":"Proc Natl Acad Sci USA"},{"key":"378_CR13","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/humu.20005","volume":"23","author":"A Fragale","year":"2004","unstructured":"Fragale A, Tartaglia M, Wu J, Gelb BD (2004) Noonan syndrome-associated SHP2\/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2\/MAPK1 activation. Hum Mutat 23:267\u2013277","journal-title":"Hum Mutat"},{"key":"378_CR14","doi-asserted-by":"crossref","first-page":"7558","DOI":"10.1016\/S0021-9258(18)35980-5","volume":"254","author":"OW Griffith","year":"1979","unstructured":"Griffith OW, Meister A (1979) Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-N-butyl homocysteine sulfoximine). J Biol Chem 254:7558\u20137560","journal-title":"J Biol Chem"},{"key":"378_CR15","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3322\/canjclin.52.3.154","volume":"52","author":"BA Hellerstedt","year":"2002","unstructured":"Hellerstedt BA, Pienta KJ (2002) The current state of hormonal therapy for prostate cancer. CA Cancer J Clin 52:154\u2013179","journal-title":"CA Cancer J Clin"},{"key":"378_CR16","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4269\/ajtmh.1992.46.296","volume":"46","author":"BL Herwaldt","year":"1992","unstructured":"Herwaldt BL, Berman JD (1992) Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Am J Trop Med Hyg 46:296\u2013306","journal-title":"Am J Trop Med Hyg"},{"key":"378_CR17","first-page":"592","volume":"25","author":"H Jiao","year":"1997","unstructured":"Jiao H, Yang W, Berrada K, Tibrizi M, Shultz L, Yi T (1997) Macrophages from motheaten and viable motheaten mutant mice show increased proliferative response to GM-CSF: detection of potential HCP substrates in GM-CSF signal transduction. Exp Hematol 25:592\u2013600","journal-title":"Exp Hematol"},{"key":"378_CR18","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.4049\/jimmunol.162.7.3802","volume":"162","author":"KG Johnson","year":"1999","unstructured":"Johnson KG, LeRoy FG, Borysiewicz LK, Matthews RJ (1999) TCR signaling thresholds regulating T cell development and activation are dependent upon SHP-1. J Immunol 162:3802\u20133813","journal-title":"J Immunol"},{"key":"378_CR19","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1089\/10799900152434349","volume":"21","author":"G Kramer","year":"2001","unstructured":"Kramer G, Steiner GE, Sokol P, Handisurya A, Klingler HC, Maier U, Foldy M, Marberger M (2001) Local intratumoral tumor necrosis factor-alpha and systemic IFN-alpha 2b in patients with locally advanced prostate cancer. J Interferon Cytokine Res 21:475\u2013484","journal-title":"J Interferon Cytokine Res"},{"key":"378_CR20","first-page":"931","volume":"3","author":"DJ Lindner","year":"1997","unstructured":"Lindner DJ, Borden EC, Kalvakolanu DV (1997) Synergistic antitumor effects of a combination of interferons and retinoic acid on human tumor cells in vitro and in vivo. Clin Cancer Res 3:931\u2013937","journal-title":"Clin Cancer Res"},{"key":"378_CR21","first-page":"3254s","volume":"5","author":"RF Meredith","year":"1999","unstructured":"Meredith RF, Khazaeli MB, Macey DJ, Grizzle WE, Mayo M, Schlom J, Russell CD, LoBuglio AF (1999) Phase II study of interferon-enhanced 131I-labeled high affinity CC49 monoclonal antibody therapy in patients with metastatic prostate cancer. Clin Cancer Res 5:3254s\u20133258s","journal-title":"Clin Cancer Res"},{"key":"378_CR22","first-page":"4049","volume":"37","author":"DD Mickey","year":"1977","unstructured":"Mickey DD, Stone KR, Wunderli H, Mickey GH, Vollmer RT, Paulson DF (1977) Heterotransplantation of a human prostatic adenocarcinoma cell line in nude mice. Cancer Res 37:4049\u20134058","journal-title":"Cancer Res"},{"key":"378_CR23","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.1073\/pnas.95.7.3845","volume":"95","author":"TS Migone","year":"1998","unstructured":"Migone TS, Cacalano NA, Taylor N, Yi T, Waldmann TA, Johnston JA (1998) Recruitment of SH2-containing protein tyrosine phosphatase SHP-1 to the interleukin 2 receptor; loss of SHP-1 expression in human T-lymphotropic virus type I-transformed T cells. Proc Natl Acad Sci USA 95:3845\u20133850","journal-title":"Proc Natl Acad Sci USA"},{"key":"378_CR24","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S0968-0004(03)00091-4","volume":"28","author":"BG Neel","year":"2003","unstructured":"Neel BG, Gu H, Pao L (2003) The \u2018Shp\u2019ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem Sci 28:284\u2013293","journal-title":"Trends Biochem Sci"},{"key":"378_CR25","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1200\/JCO.1996.14.1.249","volume":"14","author":"PJ O\u2019Dwyer","year":"1996","unstructured":"O\u2019Dwyer PJ, Hamilton TC, LaCreta FP, Gallo JM, Kilpatrick D, Halbherr T, Brennan J, Bookman MA, Hoffman J, Young RC, Comis RL, Ozols RF (1996) Phase I trial of buthionine sulfoximine in combination with melphalan in patients with cancer. J Clin Oncol 14:249\u2013256","journal-title":"J Clin Oncol"},{"key":"378_CR26","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1038\/sj.leu.2402692","volume":"16","author":"MK Pathak","year":"2002","unstructured":"Pathak MK, Hu X, Yi T (2002) Effects of sodium stibogluconate on differentiation and proliferation of human myeloid leukemia cell lines in vitro. Leukemia 16:2285\u20132291","journal-title":"Leukemia"},{"key":"378_CR27","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.4049\/jimmunol.167.6.3391","volume":"167","author":"MK Pathak","year":"2001","unstructured":"Pathak MK, Yi T (2001) Sodium stibogluconate is a potent inhibitor of protein tyrosine phosphatases and augments cytokine responses in hemopoietic cell lines. J Immunol 167:3391\u20133397","journal-title":"J Immunol"},{"key":"378_CR28","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/S0021-9258(19)41830-9","volume":"250","author":"PG Richman","year":"1975","unstructured":"Richman PG, Meister A (1975) Regulation of gamma-glutamyl-cysteine synthetase by nonallosteric feedback inhibition by glutathione. J Biol Chem 250:1422\u20131426","journal-title":"J Biol Chem"},{"key":"378_CR29","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.1002\/1521-4141(200112)31:12<3649::AID-IMMU3649>3.0.CO;2-8","volume":"31","author":"JG Sathish","year":"2001","unstructured":"Sathish JG, Johnson KG, LeRoy FG, Fuller KJ, Hallett MB, Brennan P, Borysiewicz LK, Sims MJ, Matthews RJ (2001) Requirement for CD28 co-stimulation is lower in SHP-1-deficient T cells. Eur J Immunol 31:3649\u20133658","journal-title":"Eur J Immunol"},{"key":"378_CR30","first-page":"295","volume":"9","author":"H Shen","year":"1997","unstructured":"Shen H, Kauvar L, Tew KD (1997) Importance of glutathione and associated enzymes in drug response. Oncol Res 9:295\u2013302","journal-title":"Oncol Res"},{"key":"378_CR31","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/(SICI)1097-0045(19980401)35:1<56::AID-PROS8>3.0.CO;2-F","volume":"35","author":"N Shinohara","year":"1998","unstructured":"Shinohara N, Demura T, Matsumura K, Toyoda K, Kashiwagi A, Nagamori S, Ohmuro H, Ohzono S, Koyanagi T (1998) 5-fluorouracil and low-dose recombinant interferon-alpha-2a in patients with hormone-refractory adenocarcinoma of the prostate. Prostate 35:56\u201362","journal-title":"Prostate"},{"key":"378_CR32","first-page":"179","volume":"116","author":"LD Shultz","year":"1984","unstructured":"Shultz LD, Coman DR, Bailey CL, Beamer WG, Sidman CL (1984) \u201cViable motheaten,\u201d a new allele at the motheaten locus. I. Pathology. Am J Pathol 116:179\u2013192","journal-title":"Am J Pathol"},{"key":"378_CR33","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/0092-8674(93)90369-2","volume":"73","author":"LD Shultz","year":"1993","unstructured":"Shultz LD, Schweitzer PA, Rajan TV, Yi T, Ihle JN, Matthews RJ, Thomas ML, Beier DR (1993) Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 73:1445\u20131454","journal-title":"Cell"},{"key":"378_CR34","doi-asserted-by":"publisher","first-page":"603","DOI":"10.2174\/156801105774574658","volume":"5","author":"AB Stewart","year":"2005","unstructured":"Stewart AB, Lwaleed BA, Douglas DA, Birch BR (2005) Current drug therapy for prostate cancer: an overview. Curr Med Chem Anticancer Agents 5:603\u2013612","journal-title":"Curr Med Chem Anticancer Agents"},{"key":"378_CR35","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ejmg.2005.03.001","volume":"48","author":"M Tartaglia","year":"2005","unstructured":"Tartaglia M, Gelb BD (2005) Germ-line and somatic PTPN11 mutations in human disease. Eur J Med Genet 48:81\u201396","journal-title":"Eur J Med Genet"},{"key":"378_CR36","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1086\/340847","volume":"70","author":"M Tartaglia","year":"2002","unstructured":"Tartaglia M, Kalidas K, Shaw A, Song X, Musat DL, van der Burgt I, Brunner HG, Bertola DR, Crosby A, Ion A, Kucherlapati RS, Jeffery S, Patton MA, Gelb BD (2002) PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. Am J Hum Genet 70:1555\u20131563","journal-title":"Am J Hum Genet"},{"key":"378_CR37","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/ng772","volume":"29","author":"M Tartaglia","year":"2001","unstructured":"Tartaglia M, Mehler EL, Goldberg R, Zampino G, Brunner HG, Kremer H, van der Burgt I, Crosby AH, Ion A, Jeffery S, Kalidas K, Patton MA, Kucherlapati RS, Gelb BD (2001) Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet 29:465\u2013468","journal-title":"Nat Genet"},{"key":"378_CR38","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/ng1156","volume":"34","author":"M Tartaglia","year":"2003","unstructured":"Tartaglia M, Niemeyer CM, Fragale A, Song X, Buechner J, Jung A, Hahlen K, Hasle H, Licht JD, Gelb BD (2003) Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet 34:148\u2013150","journal-title":"Nat Genet"},{"key":"378_CR39","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/00062752-200401000-00007","volume":"11","author":"M Tartaglia","year":"2004","unstructured":"Tartaglia M, Niemeyer CM, Shannon KM, Loh ML (2004) SHP-2 and myeloid malignancies. Curr Opin Hematol 11:44\u201350","journal-title":"Curr Opin Hematol"},{"key":"378_CR40","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s00280-003-0644-6","volume":"52","author":"A Thalasila","year":"2003","unstructured":"Thalasila A, Poplin E, Shih J, Dvorzhinski D, Capanna T, Doyle-Lindrud S, Beers S, Goodin S, Rubin E, DiPaola RS (2003) A phase I trial of weekly paclitaxel, 13- cisretinoic acid, and interferon alpha in patients with prostate cancer and other advanced malignancies. Cancer Chemother Pharmacol 52:119\u2013124","journal-title":"Cancer Chemother Pharmacol"},{"key":"378_CR41","unstructured":"Vestal DJ, Yi T, Borden EC (2001) Pharmacology of interferons: inducedb proteins cell activation and antitumor activity. Cancer Chemother biother. Third Edn, pp 752\u2013778"},{"key":"378_CR42","doi-asserted-by":"crossref","first-page":"5978","DOI":"10.4049\/jimmunol.169.10.5978","volume":"169","author":"T Yi","year":"2002","unstructured":"Yi T, Pathak MK, Lindner DJ, Ketterer ME, Farver C, Borden EC (2002) Anticancer activity of sodium stibogluconate in synergy with IFNs. J Immunol 169:5978\u20135985","journal-title":"J Immunol"},{"key":"378_CR43","doi-asserted-by":"crossref","first-page":"6359","DOI":"10.4049\/jimmunol.162.11.6359","volume":"162","author":"J Zhang","year":"1999","unstructured":"Zhang J, Somani AK, Watt S, Mills GB, Siminovitch KA (1999) The Srchomology domain 2-bearing protein tyrosine phosphatase-1 inhibits antigen receptor-induced apoptosis of activated peripheral T cells. J Immunol 162:6359\u20136367","journal-title":"J Immunol"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-006-0378-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00280-006-0378-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-006-0378-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-006-0378-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T18:41:57Z","timestamp":1683657717000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00280-006-0378-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,14]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["378"],"URL":"https:\/\/doi.org\/10.1007\/s00280-006-0378-3","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11,14]]},"assertion":[{"value":"19 July 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}